Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

GLP-1 weight-loss drugs are cutting calories… and grocery bills, according to a new study from Cornell and Numerator.

TV star and comedian Katherine Ryan has responded to claims from her teenage daughter that she has been using controversial ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?